SQ Innovation, Inc.

SQ Innovation, Inc. is a Swiss biopharmaceutical company founded in 2019 with a presence in Switzerland, the USA, and the Netherlands. The company specializes in developing therapies for subcutaneous drug delivery, aiming to facilitate at-home treatments for conditions typically managed in hospitals, particularly heart failure. With a mission to produce innovative, safe, and effective combination products, SQ Innovation engages deeply in dialogue with healthcare providers and payors to improve patient care outside traditional settings. The company`s key product, Lasix ONYU, is developed to support patient recovery at home, reflecting the growing need for healthcare solutions that align with both economic and environmental responsibilities. SQ Innovation is focused on adhering to regulatory standards and customer expectations while refining its processes and products.